For the Inventor, By the Inventor

Enter assignee name

Delsitech Oy

USPTO Granted Patents = 11

% Expired Patents = 18.2

CIPO Patents = 2

EPO Patents = 7

Forward Citations = 69

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Manja Ahola (7 out of 7 patents)

Harry Gosta Jalonen (6 out of 12 patents)

Mika Jokinen (5 out of 7 patents)

4. Antti Yli-Urpo (4 out of 20 patents)

5. Pirjo Kortesuo (3 out of 14 patents)

6. Mika Koskinen (3 out of 3 patents)

7. Eija Säilynoja (3 out of 3 patents)

8. Jukka Salonen (3 out of 6 patents)

9. Ari-Pekka Forsback (2 out of 2 patents)

10. Veli-Matti Kähäri (2 out of 2 patents)

11. Heidi Fagerholm (2 out of 2 patents)

12. Ilkka Kangasniemi (2 out of 10 patents)

13. Juha Kiesvaara (2 out of 5 patents)

14. Kauko Kurkela (2 out of 3 patents)

15. Niilo Saarinen (2 out of 2 patents)

11 patents: Sort by Forward Citations

1. 10172792 - Hydrogel composite depot formulation (2019-01-08),

2. 10149825 - [object Object] (2018-12-11),

3. 9949922 - Silica hydrogel composite (2018-04-24),

4. 9226893 - Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products (2016-01-05),

5. 7897166 - Biodegradable ceramic fibres from silica sols (2011-03-01),

6. 7727543 - Biodegradable carrier and method for preparation thereof (2010-06-01),

7. 7485318 - Biodegradable carrier and method for preparation thereof (2009-02-03),

8. 7326422 - Dissolvable oxides for biological applications (2008-02-05),

9. 7112339 - Compositions for controlled release of a biologically active agent, and the preparation thereof (2006-09-26),

10. 6991802 - Multilayered material bearing a biologically active agent and the preparation thereof (2006-01-31),

11. 6764690 - Dissolvable oxides for biological applications (2004-07-20),

Delsitech Oy, based in Turku, Finland, specializes in advanced drug delivery systems, focusing on the development of innovative solutions for the pharmaceutical industry. The company is known for its expertise in utilizing cutting-edge technologies to enhance the efficacy and safety of medications. Delsitech's research primarily revolves around the formulation and manufacturing of drug delivery platforms, aiming to improve patient outcomes through tailored therapeutic solutions. Its commitment to innovation positions it as a key player in the evolving landscape of healthcare technology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#11 in Turku

#273 in Finland

#51,714 in the World

Delsitech Oy

Forward Citations = 69

22 inventors:

Manja Ahola (7 out of 7 patents)

Harry Gosta Jalonen (6 out of 12 patents)

Mika Jokinen (5 out of 7 patents)

4. Antti Yli-Urpo (4 out of 20 patents)

5. Pirjo Kortesuo (3 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…